España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Heron Therapeutics
HRTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.58
0.05
3.27%
At close: -
$1.54
-0.04
-2.53%
After Hours: 4:46 PM EDT
Get Report
Comment
Heron Therapeutics (HRTX) Forecast
News
Earnings
Heron Therapeutics (HRTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Heron Therapeutics (NASDAQ:HRTX) Stock
Heron Therapeutics Stock (NASDAQ: HRTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 04, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Heron Therapeutics shares are trading higher....
Benzinga Newsdesk
Needham Reiterates Buy on Heron Therapeutics,...
Benzinga Newsdesk
Why Marvell Technology Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, December 03, 2024
Heron Therapeutics Says US District Court Rul...
Benzinga Newsdesk
Wednesday, November 13, 2024
Starbucks To $77? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
Needham Maintains Buy on Heron Therapeutics, ...
Benzinga Newsdesk
Tuesday, November 12, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Heron Therapeutics shares are trading lower a...
Benzinga Newsdesk
Heron Therapeutics Narrows FY24 Guidance For ...
Benzinga Newsdesk
Heron Therapeutics Q3 2024 GAAP EPS $(0.03), ...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Thursday, October 10, 2024
Heron Therapeutics Reaffirms Availability And...
Benzinga Newsdesk
Wednesday, September 25, 2024
Needham Reiterates Buy on Heron Therapeutics,...
Benzinga Newsdesk
Heron Therapeutics shares are trading higher ...
Benzinga Newsdesk
Heron Therapeutics Announces FDA Approval Of ...
Benzinga Newsdesk
Wednesday, August 07, 2024
Needham Reiterates Buy on Heron Therapeutics,...
Benzinga Newsdesk
Tuesday, August 06, 2024
Heron Therapeutics Continues To Expect FY24 P...
Benzinga Newsdesk
Heron Therapeutics Q2 2024 GAAP EPS $(0.06) M...
Benzinga Newsdesk
Monday, July 15, 2024
Heron Therapeutics Announces ZYNRELEF Include...
Benzinga Newsdesk
Tuesday, July 02, 2024
Heron Therapeutics shares are trading lower. ...
Benzinga Newsdesk
Heron Therapeutics Announces The FDA Acknowle...
Benzinga Newsdesk
Monday, June 24, 2024
FDA Expands Argenx's Vyvgart Label to Treat Rare Disorder
Zacks
Thursday, June 13, 2024
Avidity Up 33% on Rare Muscle Disease Study Results
Zacks
Rodman & Renshaw Initiates Coverage On Heron ...
Benzinga Newsdesk
Wednesday, May 29, 2024
Heron Therapeutics Announces Prior Approval S...
Benzinga Newsdesk
Friday, May 24, 2024
Top 3 Health Care Stocks That May Crash In May
Avi Kapoor
Friday, May 17, 2024
Ionis, Biogen Down on Ending Development of ALS Drug
Zacks
Thursday, May 16, 2024
Needham Reiterates Buy on Heron Therapeutics,...
Benzinga Newsdesk
Wednesday, May 08, 2024
Needham Reiterates Buy on Heron Therapeutics,...
Benzinga Newsdesk
Tuesday, May 07, 2024
Heron Therapeutics shares are trading higher ...
Benzinga Newsdesk
Heron Therapeutics Reaffirms FY24 Revenue $13...
Benzinga Newsdesk
Heron Therapeutics Q1 2024 GAAP EPS $(0.02) B...
Benzinga Newsdesk
Tuesday, April 23, 2024
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Heron Therapeutics shares are trading higher ...
Benzinga Newsdesk
Capital One Initiates Coverage On Heron Thera...
Benzinga Newsdesk
Thursday, April 11, 2024
Needham Reiterates Buy on Heron Therapeutics,...
Benzinga Newsdesk
Wednesday, March 13, 2024
Why Is Postoperative Pain Focused Heron Therapeutics Stock Trading Higher On Wednesday?
Vandana Singh
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Heron therapeutics shares are trading higher ...
Benzinga Newsdesk
Needham Maintains Buy on Heron Therapeutics, ...
Benzinga Newsdesk
Tuesday, March 12, 2024
Heron therapeutics shares are trading higher ...
Benzinga Newsdesk
Heron Therapeutics: Q4 Earnings Insights
Benzinga Insights
Heron Therapeutics Sees FY24 Revenue $138M-$1...
Benzinga Newsdesk
Heron Therapeutics Q4 2023 Adj EPS $(0.07) Be...
Benzinga Newsdesk
Earnings Scheduled For March 12, 2024
Benzinga Insights
Monday, March 11, 2024
Preview: Heron Therapeutics's Earnings
Benzinga Insights
Wednesday, January 24, 2024
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch